Knowledge and attitudes about influenza and the common cold in Syria post COVID-19: A qualitative study

Swed, Sarya; Alibrahim, Hidar; Alzabibi, Mhd Amin; Shibani, Mosa; Hasoon, Mostafa; Bohsas, Haidara; Raslan, Hasan; Alholiby, Sham; Channiss, Lilas; Alsakka, Shahm Azzam; Alkassab, Rana; Barou, Salwa Abdulrahman; Kelzia, Aya; Al-Abboud, Hala; Naal, Fatima; Jarrous, Aya Mtanos; Jawish, Nagham; Suliman, Schasa Monaf; Dashan, Sedra; Esmaeel, Weaam; Shebli, Baraa; Ezzdean, Weaam; Kashkash, Fateh; Khouri, Abdullah; Sawaf, Bisher; Kakaje, Ameer; Kearney, Ruby M.; Ghozy, Sherief

doi:10.1016/j.amsu.2022.104166

Cited by 2 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most important conclusion about this value which affects the population is that the infection of the 2022 human MPOX disease starts to spread, that is, the 2022 human MPOX disease is a pandemic in its 2022 outbreak. This can be compared with the previous problem, which is the 2019 coronavirus disease 19 , 50 – 53 where it is seen that the spreading rhythm of the 2022 human MPOX disease is less than that of the 2019 coronavirus disease. Also, it is found that the values of herd immunity for the 2022 human MPOX disease are 35.52% for the United States and 30.99% for Spain.…”

Section: Discussionmentioning

confidence: 95%

The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case

Al‐Raeei

2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

As of May 2022, a new outbreak of the human monkeypox (MPOX) disease appeared in multiple countries, where the 2022 human MPOX disease spread to more than 109 cases, excluding the suspected cases up to the end of 2022. The deaths of the 2022 human MPOX exceeded 200 cases up to the same date. The human MPOX is not a new disease, this disease was once endemic in some countries on the African continent. Despite this, this disease began to spread in a number of countries around the world in 2022. The first case of the 2022 human MPOX was recorded in the United Kingdom in May. After that date, this disease began to become a pandemic in a number of other countries, such as the United States, Spain, and Brazil. The 2022 human MPOX is a type of viral disease caused by a viral virus, the MPOX virus, and this virus causes rashes and lesions over the skin of the patient, as well as in the mouth of the patient. Multiple effective indicators are employed for the study of the 2022 of the human MPOX, such as the herd immunity of the human MPOX (HIhMPOX), the basic reproduction number of the human MPOX (BRNhMPOX), and the infection period of the human MPOX. This study focuses on the study of the herd immunity of, and the basic reproduction number of the 2022 outbreak of human MPOX in multiple countries around the world. This study employed the semianalytical method of the Susceptible compartment S, Infectious compartment I, Recovered compartment R (SIR) pandemic model including the mortality for the study of the herd immunity, and the basic reproduction number of the 2022 human MPOX disease. It is found that the average value of the herd immunity for the human MPOX disease in 2022 equals to 0.2194, that is, 21.94% for multiple countries, and equals to 35.52% for the United States, and 30.99% for Spain. Also, it is found that the average value of the basic reproduction number of the 2022 human MPOX disease equals to 1.2810 for multiple countries. It is concluded from these values that 21.94% of the total susceptible population has to be immunized in an effective way to prevent the spreading of the disease. Also, based on the previous values, it is concluded that the status of the 2022 MPOX disease is spreading as a pandemic.

show abstract

Section: Discussionmentioning

confidence: 95%

The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case

Al‐Raeei

2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

show abstract

“…When facing the resurgence of similar respiratory diseases, the psychological and behavioral changes in individuals become a matter of profound consideration. Researchers investigated the psychological responses of patients to influenza and common colds post-COVID-19 pandemic ( 14 ). Findings indicate that patients now face illnesses more positively and seriously.…”

Section: Introductionmentioning

confidence: 99%

Patients’ response during the co-circulation of multiple respiratory diseases in China—based on the self-regulation common-sense model

Sun,

Wang,

Hou

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

BackgroundFollowing the COVID-19 pandemic, another large-scale respiratory epidemic has emerged in China, causing significant social impact and disruption. The article is to explore the patients’ psychological and behavioral responses to the enhancement of healthcare quality.MethodsBased on the five dimensions of the Self-Regulation Common-Sense Model, we developed an interview outline to explore the process by which patients identify disease symptoms to guide action plans and coping strategies. The researchers used a semi-structured interview format to simultaneously collect data online and offline. This study gathered data from 12 patients with mixed respiratory infections, comprising 58% females and 42% males; the average age was 30.67 years (SD 20.00), with 91.7% infected with two pathogens and 8.3% with three. The data analysis employed the KJ method, themes were inductively analyzed and categorized from semi-structured interview results, which were then organized into a coherent visual and logical pathway.Key resultsThe study identified 5 themes: (1) Autonomous Actions Prior to Seeking Medical Care; (2) Decision-Making in Seeking Hospital Care; (3) Disease Shock; (4) Public Crisis Response; (5) Information Cocoon.ConclusionThe pandemic of respiratory infectious diseases has not ceased in recent years. Following the COVID-19 pandemic, China is now facing a trend of concurrent epidemics involving multiple respiratory pathogens. This study centers on patients’ health behaviors, exploring the potential relationships among various factors that affect these behaviors. The aim is to provide references and grounds for the improvement of healthcare services when such public health events reoccur.

show abstract

Knowledge and attitudes about influenza and the common cold in Syria post COVID-19: A qualitative study

Cited by 2 publications

References 25 publications

The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case

The study of human monkeypox disease in 2022 using the epidemic models: herd immunity and the basic reproduction number case

Patients’ response during the co-circulation of multiple respiratory diseases in China—based on the self-regulation common-sense model

Contact Info

Product

Resources

About